Exagen Inc. Announces $27.2 Million Debt Refinancing
SAN DIEGO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that...
Day: October 25, 2021
Catalyst Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 9, 2021
The Company will host a Conference Call and Webcast on November 10, 2021, at 8:30 AM ESTCORAL GABLES, Fla., Oct....
Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2021 Financial Results
SAN DIEGO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical...
American Physician Partners Announces Revenue Cycle Partnership Extension with R1 to Support Its Continued Growth in Emergency Medicine Market
MURRAY, Utah, Oct. 25, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform...
X4 Pharmaceuticals to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 4, 2021
Earnings Call taking place at 9:05 a.m. ET expected to include discussion of abstracts accepted to the upcoming 63rd American...
Beyond Air® Schedules Second Fiscal Quarter 2022 Financial Results Conference Call and Webcast
Call scheduled for Thursday, November 11th at 4:30 pm Eastern TimeGARDEN CITY, N.Y., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Beyond...
Allakos Presents Data at ACG 2021 from Prospective Study Showing High Prevalence Rates of Eosinophilic Gastritis and/or Eosinophilic Duodenitis with Systematic Evaluation
– Study shows 45% (181/405) of patients with moderate-to-severe unexplained gastrointestinal symptoms who underwent upper endoscopy with biopsy met the histologic criteria...
Rain Therapeutics Hosting Research and Development (R&D) Day
Tuesday, November 9th at 11:00 am ETNEWARK, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc., (NasdaqGS: RAIN), (“Rain”),...
Amedisys to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference
BATON ROUGE, La., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
Mersana Therapeutics Announces Appointment of Mohan Bala, Ph.D., as SVP, Strategic Product Planning & Program Leadership
Brian DeSchuytner named SVP and Chief Financial OfficerCAMBRIDGE, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN),...
Presenting Sponsor Boosh To Introduce New Shelf Stable Plant-Based Mac & Cheese at Planted Expo
Vancouver, British Columbia--(Newsfile Corp. - October 25, 2021) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the "Company")...
Halberd Files Provisional Patent on Breakthrough Obesity Treatment
Jackson Center, Pennsylvania--(Newsfile Corp. - October 25, 2021) - Halberd Corporation (OTC Pink: HALB) announces the filing of a provisional...
Cardiol Therapeutics Receives Health Canada Approval for Phase II Clinical Trial of CardiolRx(TM) for Acute Myocarditis
Oakville, Ontario--(Newsfile Corp. - October 25, 2021) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
Trinity Life Sciences Formalizes Full Offering of Commercialization Services for Medical Technology Companies With New Center of Excellence
Inflection Point in the MedTech Industry as Companies Pivot from Sales Force-focused to Data-driven Webinar entitled “MedTech in the Post-COVID...
PAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer
NEW YORK--(BUSINESS WIRE)--$PAVM--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, and its digital health...
Freshfields Bolsters Life Sciences Practice With Addition of Partners Kristen Riemenschneider and Vinita Kailasanath
New Washington and Silicon Valley based lawyers follow hiring of leading life sciences transactions partner Adam Golden NEW YORK--(BUSINESS WIRE)--Freshfields...
Promore Pharma Announces that Scientific Article has Been Published on Clinical Study Results with Ropocamptide for Venous Leg Ulcers
STOCKHOLM, SE / ACCESSWIRE / October 25, 2021 / Promore Pharma (STO:PROMO) (FRA:8T0)Stockholm 25 October 2021 - Promore Pharma AB,...